Abbott Continues to Oppose Spinal Cord Stimulator Lawsuit MDL, Despite Mounting Claims

Abbott Laboratories has filed opposition to a plaintiff motion seeking to establish an MDL for consolidated pretrial proceedings involving its spinal cord stimulator devices. Approximately two dozen product liability lawsuits are currently pending against Abbott in various U.S. District Courts, with plaintiffs alleging similar defects in the implanted pain management devices.

Plaintiffs claim that Abbott failed to adequately test the devices or provide sufficient warnings about potential complications. Many complaints also allege that Abbott sales representatives altered stimulator settings without proper physician guidance or authorization. This mirrors an existing MDL structure already established by the Federal MDL panel for similar consolidated proceedings involving Boston Scientific spinal cord stimulator claims.

Spinal cord stimulators are implanted devices designed to treat chronic pain by blocking pain signals before they reach the brain. The devices consist of electrodes and a battery-powered pulse generator placed under the skin near the spine, along with an external remote control. Abbott's opposition to MDL consolidation comes as the number of claims continues to grow across the federal court system.

This is a curated brief from the PlaintiffWire news desk. Read the original report at AboutLawsuits.